Fatty liver disease refers to a condition in which fat accumulates in the liver, potentially leading to inflammation, liver damage, and fibrosis if left untreated. There are two main types of fatty liver disease:
NAFLD is more common and is frequently associated with metabolic issues such as obesity, Type II diabetes, and hypertension.
Certain genes have been linked to an increased risk of developing fatty liver disease. Key genes include:
Genetic testing can reveal whether there is a genetic predisposition to developing fatty liver disease, enabling early diagnosis and intervention. Knowledge of specific genetic variants helps physicians tailor treatment strategies for the prevention or management of fatty liver disease, adjusting therapy to the individual’s needs. This testing can determine the best preventive strategy, such as lifestyle modifications or regular liver monitoring if a genetic predisposition is detected.
Genetic analysis provides reliable information about an individual’s risk of developing fatty liver disease and allows for early preventive measures. Personalized diagnosis through genetic testing enables the selection of targeted prevention and treatment strategies, ensuring an optimized approach to managing liver health.